This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...

Karan Johar said he has been suffering from body dysmorphia, a mental health condition where individuals are excessively ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But ...

Filmmaker Karan Johar has always been vocal about his body image issues, and in a new podcast, he has opened up about ...

Novo Nordisk now expects sales to grow 13% to 21% in constant currencies this year, from 16% to 24% previously. Operating profit should grow 16% to 24% compared with a previous target of 19% to 27%.

Coming a long way in his journey, Karan Johar expresses his joy of feeling happier in his skin now. “Long story short, I know ...

Karan Johar has addressed ongoing speculation about his dramatic weight loss, firmly denying the use of weight-loss drugs ...

Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--is now no longer listed as being in short supply in the U.S. and the FDA has told anyone distributing copies of the ...

On the professional front, Gautami Kapoor was recently seen in Gyaarah Gyaarah, a thrilling adaptation of the popular Korean drama Signal. The series captivated audiences with its gripping storyline ...

In an interview, Karan Johar denied using the drug Ozempic for weight loss, and joked that he'd have found a way to monetise ...

Karan Johar has grown tired of people asking if used Ozempic or Mounjaro for his weight loss, and he's set the record ...

The weight loss company will focus on its transition into a telehealth service that helps users get prescriptions for drugs ...